This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Ginsburg, C. M. Articles by Zweighaft, T. Search for Related Content PubMed PubMed Citation Articles by Ginsburg, C. M. Articles by Zweighaft, T. Social Bookmarking                   What's this?

Treatment of Group A Streptococcal Pharyngitis in Children

Results of a Prospective, Randomized Study of Four Antimicrobial Agents

Department of Pediatrics, The University of Texas Health Science Center at Dallas, Southwestern Medical School, Dallas, Texas

George H. McCracken, JR

Department of Pediatrics, The University of Texas Health Science Center at Dallas, Southwestern Medical School, Dallas, Texas

Joel B. Steinberg

Department of Pediatrics, The University of Texas Health Science Center at Dallas, Southwestern Medical School, Dallas, Texas

Stephen D. Crow

Department of Pediatrics, The University of Texas Health Science Center at Dallas, Southwestern Medical School, Dallas, Texas

Ben F. Dildy

Department of Pediatrics, The University of Texas Health Science Center at Dallas, Southwestern Medical School, Dallas, Texas

Francis Cope

Department of Pediatrics, The University of Texas Health Science Center at Dallas, Southwestern Medical School, Dallas, Texas

Teresa Zweighaft

Department of Pediatrics, The University of Texas Health Science Center at Dallas, Southwestern Medical School, Dallas, Texas

Penicillin V, benzathine/procaine penicillin G, cefadroxil monohydrate, and erythromycin estolate were randomly assigned for therapy of group A streptococcal pharyngitis in 198 children. All patients improved within 24 hours of initiating therapy. Reinfection with a new group A streptococcal serotype occurred in 13 patients, 12 developing 7 to 12 days afrer stopping therapy and 11 becoming symptomatic. Relapse with the same organism oc curred in 16 patients, only 5 (31%) of whom were symptomatic. Antibody titer rises, antibiotic resistance of group A organisms, presence of penicillinase- producing staphylococci, and lack of compliance were not related to re current infections. There were no significant differences between the failure rates of the four test drugs: penicillin V, 12%; benzathine/procaine penicillin G, 12%; cefadroxil monohydrate, 5%; and erythromycin, 2%.

Clinical Pediatrics, Vol. 21, No. 2, 83-88 (1982)
DOI: 10.1177/000992288202100203


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				M. E. Pichichero, J. R. Casey, S. L. Block, R. Guttendorf, H. Flanner, D. Markowitz, and S. Clausen Pharmacodynamic Analysis and Clinical Trial of Amoxicillin Sprinkle Administered Once Daily for 7 Days Compared to Penicillin V Potassium Administered Four Times Daily for 10 Days in the Treatment of Tonsillopharyngitis Due to Streptococcus pyogenes in Children Antimicrob. Agents Chemother., July 1, 2008; 52(7): 2512 - 2520. [Abstract] [Full Text] [PDF]

				M. E. Pichichero The Importance of Bacteriologic Eradication in the Treatment of Group A Streptococcal Tonsillopharyngitis Clinical Pediatrics, May 1, 2007; 46(4_suppl): 3S - 16S. [Abstract] [PDF]

				C. D. Curtin, J. R. Casey, P. C. Murray, C. T. Cleary, W. J. Hoeger, S. M. Marsocci, M. L. Murphy, A. B. Francis, and M. E. Pichichero Efficacy of Cephalexin Two vs. Three Times Daily vs. Cefadroxil Once Daily for Streptococcal Tonsillopharyngitis Clinical Pediatrics, July 1, 2003; 42(6): 519 - 526. [Abstract] [PDF]

				Research in Private Pediatric Practices Clinical Pediatrics, January 1, 1991; 30(1): 12 - 14. [PDF]

				R. R. Wittler, S. M. Yamada, J. W. Bass, R. Hamill, R. A. Wiebe, and D. P. Ascher Penicillin Tolerance and Erythromycin Resistance of Group A {beta}-Hemolytic Streptococci in Hawaii and the Philippines Arch Pediatr Adolesc Med, May 1, 1990; 144(5): 587 - 589. [Abstract] [PDF]

				M. E. Pichichero, F. A. Disney, G. H. Aronovitz, C. Ginsburg, and M. Stillerman A Multicenterg Randomized, Single-blind Evaluation of Cefuroxime Axetil and Phenoxymethyl Penicillin in the Treatment of Streptococcal Pharyngitis Clinical Pediatrics, September 1, 1987; 26(9): 453 - 458. [Abstract] [PDF]

				M. Stillerman, G. H. Aronovitz, M. D. Durnell, and R. Rosenberg Comparison Between Cephalexin Two- and Four-Time Per Day Regimens in Group A Streptococcal Pharyngitis Clinical Pediatrics, June 1, 1984; 23(6): 348 - 351. [Abstract] [PDF]

				C. M. Ginsburg, G. H. McCracken Jr, S. D. Crow, B. R. Dildy, G. Morchower, J. B. Steinberg, and K. Lancaster Erythromycin Therapy for Group A Streptococcal Pharyngitis: Results of a Comparative Study of the Estolate and Ethylsuccinate Formulations Arch Pediatr Adolesc Med, June 1, 1984; 138(6): 536 - 539. [Abstract] [PDF]